International Clinical Trial: Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery: A Pragmatic, Open-Label, Randomized Superiority Trial (PROTECT-HN Trial)

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07851857) titled 'Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery: A Pragmatic, Open-Label, Randomized Superiority Trial (PROTECT-HN Trial)' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: AC Camargo Cancer Center

Condition: Surgical Wound Infection Head and Neck Neoplasms Oral Cancer Neoplasms Pharyngeal Neoplasms

Intervention: Drug: Ampicillin/Sulbactam 24-Hour Postoperative Prophylaxis

Recruitment Status: Recruiting

Phase: Phase 3

Date of First Enrollment: May 29...